BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5030578)

  • 1. Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
    Razek A; Valeriote F; Vietti T
    Cancer Res; 1972 Jul; 32(7):1496-500. PubMed ID: 5030578
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
    Valeriote FA; Tolen SJ
    Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
    [No Abstract]   [Full Text] [Related]  

  • 3. Colony forming unit suicide in normal and Rauscher leukemic mice given tritiated thymidine in vivo.
    Okunewick JP; Phillips EL
    Exp Hematol; 1974; 2(1):9-15. PubMed ID: 4455510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
    Kozinets GI; Ivanova E; Kuznetsova TV; Khanykova OK; Levina NV
    Eksp Onkol; 1985; 7(4):60-4, 76. PubMed ID: 4042959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kinetics of colony-forming and migration capabilities of bone marrow cells of (CBA X C57B1)Fi hybrid mice following desoxycorticosterone administration].
    Tsyrlova IG; Lozovoĭ VP; Kozlov VA
    Radiobiologiia; 1977; 17(1):108-10. PubMed ID: 897095
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.
    Buick RN; Messner HA; Till JE; McCulloch EA
    J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
    Marsh JC; Brown BJ; Nierenburg MM
    Cancer Res; 1983 Jun; 43(6):2962-6. PubMed ID: 6573955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Colony-forming ability of bone marrow hematopoietic cells in mice with transplanted leukemia during administration of carminomycin].
    Kozinets GI; Ivanova LE; Khanykova OK; Kuznetsova TV; Rudneva NA
    Eksp Onkol; 1984; 6(5):59-62. PubMed ID: 6510345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of murine myeloid leukemia by aclacinomycin-A based on the dynamics of leukemic colony forming unit and normal hematopoietic stem cells.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1324-32. PubMed ID: 6963084
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic precursor cells in mice treated with 4-demethoxydaunorubicin and doxorubicin.
    Massa G; Bogliolo G; D'Amore F; Muzzulini C; Ghio R; Pannacciulli I
    J Natl Cancer Inst; 1982 Jun; 68(6):971-6. PubMed ID: 6953276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dose fractionation of daunorubicin on survival of leukemic cells.
    Razek A; Valeriote F; Vietti T
    Cancer Res; 1980 Aug; 40(8 Pt 1):2835-8. PubMed ID: 7388834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
    Chute JP; Fung J; Muramoto G; Erwin R
    Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells.
    Cadman E; Eiferman F; Heimer R; Davis L
    Cancer Res; 1978 Dec; 38(12):4610-7. PubMed ID: 82479
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of hyperthermia on murine bone marrow normal colony-forming units and AKR and L1210 leukemia stem cells.
    Flentje M; Flentje D; Sapareto SA
    Cancer Res; 1984 May; 44(5):1761-6. PubMed ID: 6713379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Production of an erythropoietic factor by mouse leukemia].
    Tambourin P; Wendling F; Bucau-Varlet P; Charon M; Muller O; Casadevall N; Lacombe C; Choppin J; Varet B
    C R Seances Acad Sci III; 1983; 297(1):29-31. PubMed ID: 6416628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of hematopoietic and leukemic colony-forming cells in vivo after administration of mitomycin C or porfiromycin.
    Razek A; Valeriote F; Vietti T
    J Natl Cancer Inst; 1973 Dec; 51(6):1845-8. PubMed ID: 4765389
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum-free culture conditions for cells capable of producing long-term survival in lethally irradiated mice.
    Brown RL; Xu FS; Dusing SK; Li Q; Fischer R; Patchen M
    Stem Cells; 1997; 15(3):237-45. PubMed ID: 9170216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 20. Piperazinedione (NSC 135758) and total body irradiation as an ablative bone marrow transplantation regimen in mice.
    Zander AR; Huynh L; Spitzer G; Verma DS; Dicke KA
    Exp Hematol; 1981 Oct; 9(9):945-9. PubMed ID: 7040096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.